Physician

Samir Vermani, M.D.

According to 2025 Medicare claims, Samir Vermani, M.D. (NPI: 1790074078) practices gastroenterology in the Cincinnati, OH-KY-IN market, with the plurality of this provider's patient population coming from Kenton, KY. This provider's primary affiliated billing organization is TRI-STATE GASTROENTEROLOGY ASSOCIATES, PSC (NPI: 1306843842; TIN: 611192347) and primary practice location at 41017-3409. Vermani is affiliated with the Healthcare Solutions Network (ACO ID: A3283), participating under the MSSP model.

Vermani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 337 traditional Medicare patients, billed 14,889 HCPCS/CPT codes, and received $221,182 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,234 prescription claims across 492 beneficiaries totaling $700,073 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2023 DME data shows 24 claims. Open Payments data shows 26 records totaling $423. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $2,283 to $221,182. Similarly, Part D prescription costs have risen steadily, from $337,868 to $700,073. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	39	77	$2,283
2016	40	63	$1,696
2017	118	258	$25,263
2018	273	3,614	$58,649
2019	291	590	$55,877
2020	265	2,014	$48,179
2021	263	4,340	$71,872
2022	328	11,423	$123,389
2023	428	16,807	$185,588
2024	337	14,889	$221,182

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	22	89	$337,868
2016	20	70	$62,114
2017	57	142	$42,767
2018	116	359	$334,754
2019	175	495	$177,837
2020	188	599	$250,463
2021	197	679	$468,810
2022	230	772	$481,458
2023	404	1,091	$634,450
2024	492	1,234	$700,073

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	24	$2,387
2023	N/R	24	$2,696
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	76	77	$202
45380	Biopsy of large bowel using a flexible endoscope	94	94	$111
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	42	42	$106
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	102	124	$79
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	74	77	$52

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	12	336	$162,820
Rinvoq	Upadacitinib	20	588	$145,510
Linzess	Linaclotide	96	4,560	$82,493
Dexlansoprazole Dr	Dexlansoprazole	54	2,865	$17,163
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	203	245	$13,095

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$423	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Samir Vermani, M.D.?

Tedicare shows public-source Medicare data for Samir Vermani, M.D. (NPI 1790074078), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samir Vermani, M.D. have ACO affiliation data?

Samir Vermani, M.D. is shown with ACO affiliation data for Healthcare Solutions Network (MSSP, ACO ID A3283).

What billing organization is linked to Samir Vermani, M.D.?

Samir Vermani, M.D. is linked to TRI-STATE GASTROENTEROLOGY ASSOCIATES, PSC (billing NPI 1306843842) in the available physician profile data.

Does Samir Vermani, M.D. have Open Payments data?

Samir Vermani, M.D. has 26 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.